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Introduction 
Eosinophilic pleural effusion can be induced by a 
variety of causes: pneumonia, fungi, tuberculosis, 
hypersensitivity, malignant disease, pulmonary in- 
farction, collagen vascular disease, etc. (1). Although 
post-traumatic pleural effusion was reported as a 
cause in 16-25% of cases (1,2), its precise aetiology 
and treatment remain unclear. This report describes a 
patient with post-traumatic eosinophilic pleural 
effusion which improved dramatically with a single 
intrapleural infusion of corticosteroid. 
Case Report 
The authors were unsuccessful in their attempt to 
insert a subclavian catheter into an 80-year-old man, 
hospitalized for cerebral infarction and receiving 
total parenteral nutrition. He had no history of 
allergy, and had received only heparin, an HZ-blocker 
and total parenteral nutrition. No foreign substances 
were injected or leaked into the pleural space dur- 
ing this procedure (e.g. anti-microbial agent or 
parenteral nutrition). Examination revealed an 
euphonic man with a resting blood pressure of 1501 
72 mmHg. There were neither cardiac murmurs nor 
carotid bruits. There was moderate left hemiparesis 
of the face, arm and leg. Hyper-reflexia with a 
positive Babinski sign was also present on the left, 
and speech was dysarthric. Physical examination was 
otherwise normal. Laboratory studies revealed: white 
cell count 9700 pl- ’ with 0% eosinophils; erythro- 
cyte sedimentation rate 34 mm h- I; C-reactive 
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protein 0.2 mg dl ~ I; aspartate aminotransferase 
23 IU ml - ‘; serum creatinine 1.2 mg dl - I; immuno- 
globulin E (IgE) 123 IU ml - ‘. Chest X-ray film was 
normal on admission and immediately after the 
attempted subclavian vein puncture. Marked left- 
sided pleural effusion, however, was seen 10 days 
later on chest film. Computed tomographic (CT) scan 
of the chest also showed left-sided massive pleural 
effusion with trivial pneumothorax [Plate l(a)]. 
Thoracentesis yielded 50 ml of turbid yellow fluid. 
Gram-stained specimens of this fluid revealed 3300 
leukocytes pl- ‘, with 90% eosinophils and 2% lym- 
phocytes. Numerous cultures and subsequent smears 
from pleural fluid, sputum and gastric washings were 
negative for fungi, tubercle bacilli, pyogens and 
malignant cells. Fluid analysis revealed protein con- 
centration 3.5 g dl- ’ and glucose 60 mg dl- ’ and 
was negative for rheumatoid factor. Needle biopsied 
specimens revealed thickened pleura, consistent with 
non-specific chronic inflammation. Subsequent labo- 
ratory findings showed peripheral blood white cell 
count 9500,& ‘, with 10% eosinophils and IgE 
148 IU/ml. Serological tests for fungi, parasites and 
viruses were negative. Stool examinations were 
negative for ova and parasites. 
The clinical course of this case is shown in Fig. 1. 
Drainages of the pleural effusion were performed 
repeatedly over a 2-month period. Although pleural 
eosinophilia decreased from 90% to 6%, no improve- 
ment was seen in the volume of pleural effusion and 
in peripheral blood eosinophilia. Therefore, a single 
dose of 24mg dexamethasone was injected directly 
into the pleural space. The chest X-ray taken 7 days 
later showed a marked decrease in pleural effusion, 
confirmed by CT scan [Plate l(b)]. Laboratory find- 
ings revealed white cell count 7870~1~ ’ with 0% 
eosinophils and IgE 114 IU/ml. No recurrence was 
reported over 9 months of follow-up. 
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Plate I (a) Computed tomographic (CT) scan of thorax showing massive pleural effusion and mild pneumothorax. 
(b) Following CT scan of thorax showing marked decrease in pleural effusion. 
Date 7 September 8 November 18 November 24 November 27 December 4 January 
Total parenteral 
nutrition 
Corticosteroid 
+ Subclavian vein puncture 
Chest X-ray 
ESR (mm h-l) 34 54 34 56 42 35 
CRP (mg dl-l) 0.2 3.2 2.8 0.7 0.0 0.5 0.0 
WBC (C Al-l) 9700 9500 6890 8940 8330 7620 7870 7870 
Eosino 0 10 15 14 12 13 8 0 
(%; peripheral blood) 
Eosino 
(%; pleural effusion) 
90 75 57 7 6 
Fig. I Clinical course. Eosinophilic pleural effusion improved dramatically after a single direct intrapleural infusion of 
dexamethasone. ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; WBCC, white blood cell count; Eosino, 
eosinophils. 
Discussion the presence of 10% (or more) eosinophils among the 
cells in the pleural fluid, exclusive of erythrocytes (1). 
Eosinophilic pleural effusion is relatively uncom- The aetiology is diverse. Cambell and Webb sum- 
mon and an interesting phenomenon, as defined by marized the various aetiologies in 101 cases as 
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follows: idiopathic, 28; infection (pneumonia, tuber- 
culosis, fungal, empyema), 24; trauma (pneumotho- 
rax, rib fracture, thoractomy), 16; hypersensitivity 
(asthma, vascular allergy, dermatitis, transitory pul- 
monary infiltration), 14; malignancy, 6; pulmonary 
infarction, 5; heart failure, 4; rheumatoid arthritis, 2; 
cirrhosis, 1; sarcoidosis, 1 (1). Although the exact 
mechanism for eosinophilic pleural effusion is 
unclear, it is suggested that injection of erythrocytes 
into the peritoneal cavity of mice produces an effu- 
sion with a high eosinophil count and persistent 
peripheral eosinophilia (3). This study suggests that a 
foreign protein or its split products may be a stimu- 
lating factor (4). Some investigators indicate that 
eosinophilic chemotactic factors are associated with 
complex immune reactions, such as lymphokines, 
histamine, anaphylactic factors and tumour- 
associated eosinophilic chemotactic factors (5,6). 
The diagnosis of post-traumatic eosinophilic 
pleural effusion in the present case was made based 
on his clinical course, cytological findings of the 
pleural effusion, radiographic findings complicated 
with pneumothorax, and absence of evidence for 
other aetiologies including infection. Despite 
repeated drainage, an atypical massive pleural 
effusion with peripheral eosinophilia persisted for 2 
months. Bando et al. and Beekman et al. previously 
reported similar cases with peripheral blood 
eosinophilia and a high level of serum IgE. They 
speculated that an immunologic reaction could 
be one of the aetiologies of persistent eosinophilic 
pleural effusion (5,7). 
Repeated drainage of eosinophilic pleural effusion 
is worthwhile (S), because this condition has a good 
prognosis (6). Some problems, however, remain in 
cases with prolonged eosinophilic pleural effusion. 
Recent investigators have reported the clinical 
efficacy of systemic corticosteroid administration, 
and have proposed that an immune reaction may 
be responsible, at least in cases with peripheral 
eosinophilia (9). Peripheral eosinophilia and 
increased serum IgE observed in the present case 
suggested that the immunologic reaction may induce 
and/or prolong the eosinophilic pleural effusion. 
Therefore, the authors considered that it might be 
useful to administer corticosteroid directly into the 
pleural space. 
Although the precise mechanism of corticosteroid 
therapy for eosinophilic pleural effusion is unclear, it 
is well known that corticosteroid therapy prevents 
the entry of eosinophils into the site of inflammation 
(10). Blackwell et al. have reported that both exudate 
volume and leukocyte number in pleural fluid are 
reduced significantly by local injection of dexametha- 
sone in carrageenin-induced pleuritis in rat. They 
have also shown that both the anti-phospholipase 
and anti-flammatory activities of the pleural proteins 
are increased by steroids (11). The significant 
decrease in IgE and the decrease in peripheral blood 
eosinophils in the present case may support this 
hypothesis. 
The reported two cases with post-traumatic pleural 
effusion treated successfully with intrapleural steroids 
were not complicated with pneumothorax (7,12). The 
present case suggests that intrapleural corticosteroid 
injection therapy may be available not only for 
post-traumatic eosinophilic pleural effusion, but also 
for eosinophilic pleural effusion following pneumo- 
thorax. Further studies are required to determine the 
optimal dose, indication and mechanisms for its 
clinical efficacy. 
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